Home \ Expert opinion \ glaucoma and age -related macular degeneration in clinical practice

Glaucoma and age -related macular degeneration in clinical practice

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:00
About glaucoma and its interdisciplinary nature
03:00
Embryogenesis and the structure of the visual analyzer, pathogenesis of glaucoma
04:00
Signs by which the doctor can suspect the development of glaucoma
06:23
Expanding the possibilities of drug treatment of glaucoma
09:49
The role of neurocytoprotectors in the treatment of glaucoma
14:59
The effectiveness of the drug Mexidol® in the treatment of glaucoma - research
19:00
The positive effect of antioxidant Mexidol® on visual functions in patients with glaucoma

Ekusheva Evgenia Viktorovna - MD, professor, head. Department of Nervous Diseases and Neurorebition of the Academy of Postgraduate Education of the Federal State Budgetary Educational Institution of the FGBC FMBA of Russia

Egorov Evgeny Alekseevich - MD, professor, president of the Russian glaucomal society, head. Department of ophthalmology named after Academician A.P. Nesterova Rnim them. N.I. Pirogov

Announcement:

Glaucoma is a disease in which intraocular pressure increases. This leads to damage to the optic nerve and loss of vision. However, do not despair! Early diagnosis, correct therapy and the use of neurocytoprotexts can prevent vision loss. The role of hypoxia, chemical disorders and oxidative stress in the pathogenesis of glaucoma is undeniable. But what place does neurocytoprotectors occupy in patients with glaucoma? Studies show that neurocytoprotectors play an important role in preserving visual functions in patients with this disease. They help maintain the survival of the ganglion cells of the retina and slow down the degeneration of the optic nerve. One of the trusted neurocytoprotectors is Mexidol®. Studies of the drug Mexidol® confirm its high efficiency in the fight against glaucoma and other diseases of the optic nerve.

All video next video

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:00
About glaucoma and its interdisciplinary nature
03:00
Embryogenesis and the structure of the visual analyzer, pathogenesis of glaucoma
04:00
Signs by which the doctor can suspect the development of glaucoma
06:23
Expanding the possibilities of drug treatment of glaucoma
09:49
The role of neurocytoprotectors in the treatment of glaucoma
14:59
The effectiveness of the drug Mexidol® in the treatment of glaucoma - research
19:00
The positive effect of antioxidant Mexidol® on visual functions in patients with glaucoma

Block of articles on this topic

The effect of antioxidant therapy on some pathogenetic factors of primary open -angle glaucoma

Authors:
T.N. Malishevskaya ¹ , Yu.E. Filippova ²

¹ FSBI "National Medical Research Center of Eye Diseases named after Helmholtz »Ministry of Health of Russia, Moscow, Russia;
² GAUZ “Regional Ophthalmological Dispensary”, Tyumen, Russia

Mexidol in the complex treatment of glaucoma

Author:
E.A. Egorov, N.G. Davydova, I.A. Romanenko, N.D. Novikova

RNIMU named after N.I. Pirogov, GB of GB named after Helmholtz, Moscow

The possibilities and results of the use of antioxidant therapy in ophthalmological practice

Authors:
A.B. Movsisyan ^1.2 , J.G. Oganezova ^2.3 , E.A. Egorov ²

¹ GBUZ “Hospital for Wars of Wars No. 2 DZM”, Moscow, Russia;
² FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
³ FGBNU "Medical and Genetical Scientific Center named after Acad. N.P. Bochkova ", Moscow, Russia

The experience of neuroprotective therapy of primary open -angle glaucoma based on the use of various forms of Mexidol

Authors:
E.S. Leonova ^1.2 , S.V. Polyakov ^1.2 , M.A. Pozdnyakova ² , E.P. Yarygina ³ , S.O. Semisinov ²

¹ NUZ "Road Clinical Hospital at the Gorky station OJSC" Russian Railways ", the interdorrutal center of ophthalmology
² GBOU VPO" Nizhny Novgorod State Medical Academy "
³ GBUZ but" City Hospital No. 35 ", City Glacks Center

The use of Mexidol in the treatment of primary open -angle glaucoma

Authors:
I.A. Loskutov, O.M. Andryukhina, A.A. Kovrizhkina

Moscow Regional Research Clinical Institute. M.F. Vladimir

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com